These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38020097)

  • 1. Carbonic anhydrase inhibitors limit complications in X-linked retinoschisis.
    Wey S; Brill DA; Miraldi Utz V; Sisk RA
    Front Med (Lausanne); 2023; 10():1281068. PubMed ID: 38020097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term functional and structural outcomes in X-linked retinoschisis: implications for clinical trials.
    Fenner BJ; Russell JF; Drack AV; Dumitrescu AV; Sohn EH; Russell SR; Boldt HC; Affatigato LM; Hoffmann JM; Andorf JL; Stone EM; Han IC
    Front Med (Lausanne); 2023; 10():1204095. PubMed ID: 37396901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Carbonic Anhydrase Inhibitors on Cystoid Fluid Collections and Visual Acuity in Patients with X-Linked Retinoschisis.
    Hensman J; Hahn LC; van Schooneveld MJ; Diederen RMH; Ten Brink JB; Florijn RJ; Bergen AA; Strubbe I; Heutinck P; van Genderen MM; van den Born LI; Thiadens AA; de Zaeytijd J; Leroy BP; Hoyng CB; Boon CJF
    Ophthalmol Retina; 2024 Jun; 8(6):600-606. PubMed ID: 38104928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic anhydrase inhibitors in patients with X-linked retinoschisis: effects on macular morphology and function.
    Testa F; Di Iorio V; Gallo B; Marchese M; Nesti A; De Rosa G; Melillo P; Simonelli F
    Ophthalmic Genet; 2019 Jun; 40(3):207-212. PubMed ID: 31149861
    [No Abstract]   [Full Text] [Related]  

  • 5. Carbonic Anhydrase Inhibitors for the Treatment of Cystic Macular Lesions in Children With X-Linked Juvenile Retinoschisis.
    Verbakel SK; van de Ven JP; Le Blanc LM; Groenewoud JM; de Jong EK; Klevering BJ; Hoyng CB
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5143-5147. PubMed ID: 27699410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-Linked Retinoschisis: Deep Phenotyping and Genetic Characterization.
    Georgiou M; Finocchio L; Fujinami K; Fujinami-Yokokawa Y; Virgili G; Mahroo OA; Webster AR; Michaelides M
    Ophthalmology; 2022 May; 129(5):542-551. PubMed ID: 34822951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STRUCTURAL AND FUNCTIONAL MONITORING OF EXTRAMACULAR CYSTOID SPACES IN A CASE OF X-LINKED RETINOSCHISIS TREATED WITH ACETAZOLAMIDE.
    Collison FT; Fishman GA
    Retin Cases Brief Rep; 2018 Fall; 12(4):318-321. PubMed ID: 27984356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype Heterogeneity and the Association Between Visual Acuity and Outer Retinal Structure in a Cohort of Chinese X-Linked Juvenile Retinoschisis Patients.
    Guo Q; Li Y; Li J; You Y; Liu C; Chen K; Li S; Lei B
    Front Genet; 2022; 13():832814. PubMed ID: 35309139
    [No Abstract]   [Full Text] [Related]  

  • 9. Dramatic regression of macular and peripheral retinoschisis with dorzolamide 2 % in X-linked retinoschisis: a case report.
    Sadaka A; Sisk RA
    J Med Case Rep; 2016 Jun; 10(1):142. PubMed ID: 27246168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TOPICAL CARBONIC ANHYDRASE INHIBITORS IN THE LONG-TERM TREATMENT OF JUVENILE X-LINKED RETINOSCHISIS.
    Schmitt MA; Wang K; DeBenedictis MJ; Traboulsi EI
    Retina; 2022 Nov; 42(11):2176-2183. PubMed ID: 35982512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological and functional parameters in X-linked retinoschisis patients-A multicentre retrospective cohort study.
    Kiraly P; Seitz IP; Abdalla Elsayed MEA; Downes SM; Patel CK; Charbel Issa P; Birtel J; Mautone L; Dulz S; Atiskova Y; Herrmann P; Vrabič N; Jarc-Vidmar M; Hawlina M; Fischer MD
    Front Med (Lausanne); 2023; 10():1331889. PubMed ID: 38351967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diurnal variations of foveoschisis by optical coherence tomography in patients with RS1 X-linked juvenile retinoschisis.
    Abalem MF; Musch DC; Birch DG; Pennesi ME; Heckenlively JR; Jayasundera T
    Ophthalmic Genet; 2018 Aug; 39(4):437-442. PubMed ID: 29902095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis.
    Genead MA; Fishman GA; Walia S
    Arch Ophthalmol; 2010 Feb; 128(2):190-7. PubMed ID: 20142541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Widefield Fluorescein Angiography Findings in Pediatric Patients with X-Linked Retinoschisis.
    Al-Khersan H; Sengillo J; Fan KC; López-Cañizares A; da Cruz NFS; Patel NA; Berrocal AM
    Ophthalmol Retina; 2023 Jul; 7(7):639-643. PubMed ID: 36805350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of adult-onset acute macular retinoschisis in enhanced s-cone syndrome with oral acetazolamide.
    Iannaccone A; Fung KH; Eyestone ME; Stone EM
    Am J Ophthalmol; 2009 Feb; 147(2):307-312.e2. PubMed ID: 18835469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibition in X-linked retinoschisis: An eye on the photoreceptors.
    Ambrosio L; Williams JS; Gutierrez A; Swanson EA; Munro RJ; Ferguson RD; Fulton AB; Akula JD
    Exp Eye Res; 2021 Jan; 202():108344. PubMed ID: 33186570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Of men and mice: Human X-linked retinoschisis and fidelity in mouse modeling.
    Vijayasarathy C; Sardar Pasha SPB; Sieving PA
    Prog Retin Eye Res; 2022 Mar; 87():100999. PubMed ID: 34390869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of genetic and clinical characteristics of 30 patients with X-linked juvenile retinoschisis in China.
    Gao FJ; Dong JH; Wang DD; Chen F; Hu FY; Chang Q; Xu P; Liu W; Li JK; Huang Y; Wu JH; Xu GZ
    Acta Ophthalmol; 2021 Jun; 99(4):e470-e479. PubMed ID: 33124204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral fundus findings in X-linked retinoschisis.
    Fahim AT; Ali N; Blachley T; Michaelides M
    Br J Ophthalmol; 2017 Nov; 101(11):1555-1559. PubMed ID: 28348004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cystic cavities in X-linked juvenile retinoschisis: The first sequential cross-over treatment regimen with dorzolamide.
    Coussa RG; Kapusta MA
    Am J Ophthalmol Case Rep; 2017 Dec; 8():1-3. PubMed ID: 29260104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.